Remove Drug Development Remove Life Science Remove Meeting Remove Patient Experience
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. It enables the delivery of traditional, hybrid and decentralised clinical trials while enhancing the patient experience.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. However, we are still missing the mark with patient involvement to make durable healthcare change towards a culture of patient centricity.

BioTech 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

Now, with this Series B funding, we are excited to partner with Bradford Whitmore, SeedtoB Capital, and the Rash Family Office in support of what the AngelEye team is building to elevate the neonatal experience now and into the future.”. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

That type of delivery is yet to be developed, but the data that drives it is being generated in terabytes every second of the day. Its ability to synchronise monitoring of patients at home or at local clinics and to provide diagnostic, treatment and clinical trials intelligence can be transformative.